Avantor Inc., a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has opened its new flagship Bridgewater Innovation Center. The research and development facility, located in Bridgewater, NJ, is part of Avantor’s network of 13 research and innovation centers across the globe.
 
Avantor’s newly established Bridgewater Innovation Center covers 60,000 square feet, which is twice the size of its earlier laboratory and pilot plant facilities. Specifically designed for collaborative work, this center features areas for both upstream and downstream process development, specialized analytical testing laboratories, and a viral vector lab. Additionally, a larger pilot plant facilitates scale-up simulations, allowing for quick tailoring throughout the entire bioprocessing workflow.
 
“Our new Bridgewater Innovation Center is twice the size of our previous facility and adds capacity, talent and capabilities to support the growing demands for monoclonal antibodies, cell and gene therapy and mRNA workflows,” said Michael Stubblefield, President and CEO of Avantor. “Working side-by-side with customers in our network of innovation centers across the globe enables us to power science at every step to deliver life-changing therapies faster, and more cost effectively.”
 
The Bridgewater Innovation Center allows Avantor to optimize and accelerate biomanufacturing processes at scale, resulting in faster problem-solving, streamlined knowledge exchange, and strategic co-innovation. Staffed with Ph.D. scientists, bioengineers, biologists, and process engineers, this center enhances both capacity and expertise to support customers’ needs. The facility also supports Avantor’s sustainability goals, reinforcing the company’s commitment to environmental responsibility.

Related News